Japan Coronary Vascular Closure Devices Market Report 2018 - ResearchAndMarkets.com

The "Japan Market Report for Coronary Vascular Closure Devices 2018 - MedCore" report has been added to ResearchAndMarkets.com's offering.

The gold standard in this market is manual compression. Although effective, this approach is wasteful of man-power, with perhaps 20 minutes to several hours of compression time required. With the general shortage of nursing labor, many hospitals are finding it cost-effective to employ VCDs to accelerate the closure process.

There are two types of vascular closure devices: invasive and non-invasive. Invasive devices operate by inserting a device component into the arterial hole and causing closure by various mechanisms (including sutures and collagen sponges). Non-invasive devices act at the exterior of the skin to achieve hemostasis. In addition, there are two main forms of non-invasive devices: patches and inflatable pressure bulbs. For the purposes of this report, this chapter will not be broken down to separate segments.

Key Topics Covered:

EXECUTIVE SUMMARY

1. RESEARCH METHODOLOGY

2. DISEASE OVERVIEW

2.1 BASIC ANATOMY

2.2 DISEASE TREATMENTS AND DIAGNOSTICS

2.2.1 General Diagnostics

2.2.2 Coronary Artery Disease (CAD)

2.2.3 Myocardial Infarction (MI)

2.2.4 Angina Pectoris

2.3 PATIENT DEMOGRAPHICS

2.3.1 General Statistics

3. PRODUCT ASSESSMENT

3.1 PRODUCT PORTFOLIOS

3.1.1 Coronary Vascular Closure Device Market

3.2 REGULATORY ISSUES AND RECALLS

3.2.1 Boston Scientific

3.2.2 Cardinal Health

3.2.3 Cook Medical

3.2.4 Cordis (Cardinal Health)

3.2.5 Medtronic

3.2.6 Merit Medical Systems

3.2.7 Spectranetics

3.2.8 St. Jude Medical (Abbott Laboratories)

3.2.9 Vascular Solutions (Teleflex)

3.2.10 Volcano Therapeutics (Philips Volcano)

3.2.11 Other Companies

3.2.11.1 Coronary Stent and other Vascular Stents

3.2.11.2 PTCA balloon catheter

3.2.11.3 Interventional Coronary Catheters and Guidewires

3.2.11.4 Coronary Atherectomy Device

3.2.11.5 Coronary Introducer Sheath

3.2.11.6 Intravascular Ultrasound (IVUS) Catheter

3.3 CLINICAL TRIALS

3.3.1 Abbott Laboratories

3.3.1.1 Coronary Stent

3.3.2 Asahi Intecc

3.3.2.1 Interventional Coronary Catheters and Guidewires

3.3.3 B. Braun

3.3.4 Biosensors

3.3.5 Biotronik

3.3.6 Boston Scientific

3.3.7 Medtronic

3.3.8 St. Jude Medical (Abbott Laboratories)

3.3.9 Terumo Interventional Systems (TIS)

3.3.10 Other Companies

3.3.10.1 Coronary Stent

3.3.10.2 PTCA balloon catheter

3.3.10.3 Interventional Coronary Catheters and Guidewires

3.3.10.4 Coronary Embolic Protection Device

3.3.10.5 Coronary Chronic Total Occlusion Crosser CTO

3.3.10.7 Fractional Flow Reserve (FFR) Guidewire

3.3.10.8 Optical Coherence Tomography (OCT) Guidewire

4. CORONARY VASCULAR CLOSURE DEVICE MARKET

4.1 INTRODUCTION

4.2 MARKET ANALYSIS AND FORECAST

4.3 DRIVERS AND LIMITERS

4.3.1 Market Drivers

4.3.2 Market Limiters

4.4 COMPETITIVE MARKET SHARE ANALYSIS

For more information about this report visit https://www.researchandmarkets.com/research/trb9ql/japan_coronary?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20180718005774/en/